Becton Dickinson and Co (BDX)

Common Stock

Sell: $194.00|Buy: $198.40|Change: 0.66 (-0.34%)

Open

$195.10

Previous close

$195.36

Trade high

$196.98

Volume

3,319,352

Year high

$251.985

Year low

$162.29

Dividend yield

2.13%

Market capitalisation

$55.57 bn

P/E ratio

33.57

ISIN

US0758871091

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Dividends

	Previous	Latest
Record date	08/09/2025	08/12/2025
Ex-dividend date	08/09/2025	08/12/2025
Payment date	30/09/2025	31/12/2025
Amount	$1.04	$1.05

Performance 18/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Becton Dickinson and Co	- 0.34
More...

Company profile

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents,as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43%of the company's business.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.